Search for: "VANDA PHARMACEUTICALS INC."
Results 21 - 40
of 44
Sort by Relevance
|
Sort by Date
Medical Treatment Patent Claims Held Patentable Subject Matter Under the Alice/Mayo Section 101 Test
30 Apr 2019, 7:10 pm
In Vanda Pharmaceuticals Inc. v. [read post]
1 Apr 2019, 9:59 pm
In reversing the District Court, the Federal Circuit determined that the asserted claims of the '737 patent are legally indistinguishable from the claims at issue in Vanda Pharmaceuticals Inc. v. [read post]
28 Mar 2019, 11:01 am
Id.at col. 10 ll. 26–27, 40–41.We held similar claims patent-eligible in Vanda Pharmaceuticals Inc. v. [read post]
28 Mar 2019, 9:07 am
See Vanda Pharmaceuticals Inc. v. [read post]
21 Mar 2019, 9:45 am
The court made hay of the decision in Vanda Pharmaceuticals Inc. v. [read post]
18 Mar 2019, 9:56 am
Vanda Pharmaceuticals Inc., No. 18-817 (Supreme Court 2019) In this case, the Supreme Court has requested input from the U.S. [read post]
13 Mar 2019, 9:10 am
Vanda Pharmaceuticals Inc., No. 18-817 (presumptive eligibility of method-of-treatment claims) Two final pending cases have to do with defining prior art and priority: Macor v. [read post]
27 Feb 2019, 4:14 pm
Vanda Pharmaceuticals Inc. [read post]
8 Feb 2019, 9:45 am
Hikma Pharmaceuticals USA Inc. v. [read post]
31 Dec 2018, 3:18 pm
Prometheus Labs., Inc., 566 U.S. 66, 72-73 (2012). [read post]
25 Dec 2018, 10:00 pm
Vanda Pharmaceuticals Inc. v. [read post]
29 Sep 2018, 8:09 pm
Teva Parenteral Medicines Inc. -- Vanda Pharmaceuticals Inc. v. [read post]
4 Sep 2018, 11:16 am
Following the Federal Circuit’s decision in Vanda Pharmaceuticals Inc. v. [read post]
9 Jul 2018, 8:51 pm
Patent and Trademark Office, the Office addresses a recent decision by the Federal Circuit in Vanda Pharmaceuticals Inc. v. [read post]
18 Jun 2018, 7:55 am
On June 7, 2018, the USPTO issued new guidance to its examining corps in the form of a memorandum discussing the Federal Circuit’s April 13, 2018 decision in Vanda Pharmaceuticals Inc. v. [read post]
18 Jun 2018, 7:55 am
On June 7, 2018, the USPTO issued new guidance to its examining corps in the form of a memorandum discussing the Federal Circuit’s April 13, 2018 decision in Vanda Pharmaceuticals Inc. v. [read post]
26 May 2018, 1:17 pm
Although Vanda Pharmaceuticals Inc. v. [read post]
18 May 2018, 8:54 am
Praxair Distribution, Inc. v. [read post]
16 May 2018, 6:15 am
The Federal Circuit’s decision in Vanda Pharmaceuticals Inc. v. [read post]
16 May 2018, 6:15 am
The Federal Circuit’s decision in Vanda Pharmaceuticals Inc. v. [read post]
